Regulatory News
Monday, March 21, 2016
BRIEF-Endo evaluating number of options regarding Voltaren gel
* Endo provides statement regarding expected FDA approval of
generic Voltaren gel product
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment